Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease

Archives of Neurology

Volumn 53, Issue 5, 1996, Pages 428-434

  Victoroff, Jeff ^a,c,d   Zarow, Chris ^a,c   Mack, Wendy J ^b   Hsu, Edward ^c   Chui, Helena C ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGGRESSION; AGITATION; ALZHEIMER DISEASE; ARTICLE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK ASSESSMENT; SUBSTANTIA NIGRA; VIOLENCE;

EID: 0029901361     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550050058024     Document Type: Article

References (75)

1. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg Z Psychiatr Psych Gericht Med. 1907;64:46-148.
2. Cummings JL, Victoroff JI. Noncognitive neuropsychiatric syndromes in Alzheimer's disease. Neuropsychiatry Neuropsychol Behav Neurol. 1990,3140-158
3. Gilchrist PN, Rozenbilds UT, Martin E, Connolly M. A study of 100 consecutive admissions to a psychogeriatric unit Med J Aust 1985;143:236
4. Ryden MB Aggressive behavior in persons with dementia who live in the community. Alzheimer Dis Assoc Disord. 1988;2 342-355.
5. Pruchno RA, Resch NL Aberrant behaviors and Alzheimer's disease: mental health effects on spouse caregivers. J Gerontol Soc Sci. 1989;44:S177-S182.
6. O'Donnell BF, Drachman OA, Barnes HJ, Peterson KE, Swearer JM, Lew RA. Incontinence and troublesome behaviors predict institutionalization in dementia. J Geriatr Psychiatry Neurol. 1992;5:45-52.
7. Cohen-Mansfield J, Billig N. Agitated behaviors in the elderly, l: a conceptual review. J Am Geriatr Soc. 1986;34:711-721.
8. Reisberg B, Borenstein J, Salob SP, Ferris SH, Franssen E, Georgotas A. Behavioral symptoms in Alzheimer's disease: phenomenology and treatment J Clin Psychiatry. 1987,48(suppl):9-15.
9. Ten L, Larson EB, Reifler BV. Behavioral disturbance in dementia of the Alzheimer's type. J Am Geriatr Soc. 1988;36:1-6.
10. Merriam AE, Aronson MK, Gaston P, Wey SL, Katz I. The psychiatric symptoms of Alzheimer's disease. J Am Geriatr Soc. 1988;36:7-12.
11. Patterson MB, Schnell AH, Martin RJ, Mendez MF, Smyth KA, Whitehouse PJ. Assessment of behavioral and affective symptoms in Alzheimer's disease. J Geriatr Psychiatry Neurol. 1990;3:21-30.
12. Cohen CA, Gold DP, Shulman KI, Wortley JT, McDonald G, Wargon M. Factors determining the decision to institutionalize dementing individuals: a prospective study. Gerontologist 1993;331:714-720.
13. Burns A, Jacoby R, Levy R. Psychiatric phenomena in Alzheimer's disease, IV: disorders of behaviour. Br J Psychiatry. 1990,157:86-94.
14. Hamel M, Gold DP, Andres D, et al. Predictors and consequences of aggressive behavior by community-based dementia patients. Gerontologist. 1990;30: 206-211.
15. Deutsch LH, Bylsma FW, Rovner BW, Steele C, Folstein MF. Psychosis and physical aggression in probable Alzheimer's disease. Am J Psychiatry. 1991; 148:1159-1163.
16. Paveza GJ, Cohen D, Eisdorfer C, et al. Severe family violence and Alzheimer's disease: prevalence and risk factors. Gerontologist. 1992;32:491-497.
17. Cooper JK, Mungas D. Risk factor and behavioral differences between vascular and Alzheimer's dementias the pathway to end-stage disease. J Geriatr Psychiatry Neurol. 1993;1:29-33.
18. Swearer JM, Drachmen DA, O'Donnell BF, Mitchell AL. Troublesome and disruptive behaviors in dementia: relationships to diagnosis and disease severity. J Am Geriatr Soc. 1988;36:784-790.
19. Lopez OL, Becker JT, Brenner RP, Rosen J, Bajulaiye OI, Reynolds CF, Alzheimer's disease with delusions and hallucinations: neuropsychological and electroencephalographic correlates. Neurology. 1991;41:906-912
20. Lachs MS, Becker M, Siegal AP, Miller RL, Tinetti ME. Delusions and behavioral disturbances in cognitively impaired elderly persons. J Am Geriatr Soc. 1992;40:768-773.
21. Colenda CC, Hamer RM. Antecedents and interventions for aggressive behavior of patients at a geropsychiatric hospital. Hosp Commun Psychiatry. 1991; 42:287-292.
22. Bridges-Parlet S, Knopman D, Thompson T. A descriptive study of physically aggressive behavior in dementia by direct observation. J Am Geriatr Soc. 1994, 42:192-197.
23. Palmer AM, Stratmann GC, Procter AW, Bowen DM. Possible neurotransmitter basis of behavioral changes in Alzheimer's disease. Ann Neurol. 1988;23: 616-620.
24. Schneider LS, Severson JA, Chui HC, Pollock VE, Sloane RB, Fredrickson ER. Platelet tritiated imipramine binding and MAO activity in Alzheimer's disease patients with agitation and delusions. Psychiatry Res. 1988;25:311-322
25. Procter AW, Francis PT, Stratmann GC, Bowen DM. Serontonergic pathology is not widespread in Alzheimer patients without prominent aggressive symptoms. Neurochem Res 1992,17 917-922
26. Raskind MA, Peskind ER, Wingerson D, Pascualy M, Dobie DJ, Veith RC. Enhanced cerebrospinal fluid norepinephrine response to yohimbine in aging and Alzheimer's disease. Soc Neurosci Abstr. 1993;19:400.
27. Sunderland T, Silver MA. Neuroleptics in the treatment of dementia Int J Geriatr Psychiatry. 1988;3:79-88.
28. Schneider LS, Pollock VE, Lyness SA. A meta-analysis of controlled trials of neuroleptic treatment in dementia. J Am Geriatr Soc. 1990;38:553-563.
29. Tariot PN, Cohen RM, Sunderland T, et al. L-Deprenyl in Alzheimer's disease. Arch Gen Psychiatry. 1987,44:427-433.
30. Simpson DM, Foster D. Improvement in organically disturbed behavior with trazodone treatment. J Clin Psychiatry. 1986;47.191-193.
31. Lebert F, Pasquier F, Petit H Behavioral effects of trazadone in Alzheimer's disease. J Clin Psychiatry. 1994;55:536-538
32. Petrie WM, Ban TA Propranolol in organic agitation. Lancet. 1981;1:324.
33. Weiler PG, Mungas D, Bernick C Propranolol for the control of disruptive behavior in senile dementia. J Geriatr Psychiatry Neurol. 1988;1:226-230.
34. Gorman DG, Read S, Cummings JL. Cholinergic therapy of behavioral disturbances in Alzheimer's disease Neuropsychiatry Neuropsychol Behav Neurol. 1993;6:229-234.
35. Kaufer DI, Cummings JL Does dementia severity predict response to tacrine in Alzheimer's disease? Neurology. 1995;45(suppl 4).A471-A472. Abstract.
36. Chui HC, Bondareff W, Zarow C, Slager U. Stability of neuron number in the human nucleus basalis of Meynert with age Neurobiol Aging 1984;5:83-88.
37. Zarow C, Chui HC A simple method for assessing neuronal numbers in the human substantia nigra. Soc Neurosci Abstr. 1991;17:1450.
38. Bondareff W, Mountjoy CQ. Number of neurons in locus ceruleus in demented and non-demented patients: rapid estimation and correlated parameters. Neurobiol Aging, 1986;7:297-300
39. Mirra SS, Heyman A, McKeel D, et al, and participating CERAD neuropathologists The Consortium to Establish a Registry for Alzheimer's Disease, II: standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-486.
40. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders, Third Edition. Washington, DC: American Psychiatric Association; 1980.
41. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984;34:939-944.
42. Raskin A, Crook T. Relative's assessment of global symptomatology (RAGS). Psychopharmacol Bull. 1988;24:759-763.
43. Cohen-Mansfield J Agitated behaviors in the elderly, II: preliminary results in the cognitively deteriorated. J Am Geriatr Soc. 1986;34:722-727.
44. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale tor the staging of dementia. Br J Psychiatry. 1982;140.566-572.
45. Folstein M, Folstein S, McHugh PR Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12:189-198.
46. Ditter SM, Mirra SS Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology. 1987;37:754-760.
47. Morris JC, Drazner M, Fulling K, Grant EA, Goldring J. Clinical and pathological aspects of parkinsonism in Alzheimer's disease: a role for extranigral factors? Arch Neurol. 1989,46:651-657.
48. Kazee AM, Cox C, Richfield EK. Substantia nigra in Alzheimer's disease and normal aging. Alzheimer Dis Assoc Disord. 1995;9:61-67.
49. Thiessen B, Rajput AH, Laverty W, Desai H. Age, environment, and the number of substantia nigra neurons. Adv Neurol. 1990;53:201-206
50. Palmer AM, DeKosky ST. Monoamine neurons in aging and Alzheimer's disease. J Neural Transm Gen Sect. 1993;91:135-159.
51. Torack RM, Morris JC. The association of ventral tegmental area histopathology with adult dementia Arch Neurol. 1988;45.497-501.
52. Sumi SM, Bird TD, Nochlin D, Raskind MA. Familial presenile dementia with psychosis associated with cortical neurofibrillary tangles and degeneration of the amygdala. Neurology. 1992,42:120-127.
53. Fallon JH. Topographic organization of ascending dopaminergic projections. In. Kalivas PW, Nemeroff CB, eds. The Mesocorticolimbic Dopamine System. New York, NY: NY Academy of Sciences; 1988:1-9.
54. Nauta HJW. The relationship of the basal ganglia to the limbic system. In: Vinken PJ, Bruyn GW, Klawans HL, eds. Handbook of Clinical Neurology. New York, NY: Elsevier Science Publishing Co Inc, 1986;5:19-31.
55. Parent A. Extrinsic connections of the basal ganglia. Trends Neurosci. 1990; 13:254-258.
56. Alexander GE, Crutcher MD. Functional architecture of basal ganglia circuits: neural substrates of parallel processing. Trends Neurosci. 1990;13:266-271.
57. Nikulina EM, Avgustinovicti DF, Popova NK Selection for reduced aggressiveness towards man and dopaminergic activity in Norway rats Aggress Behav. 1992;18:65-72.
58. Tufik S, Lindsey CJ, Carlini EA. Does REM sleep deprivation induce a super-sensitivity of dopaminergic receptors in the rat brain? Pharmacology. 1978; 16.98-105.
59. Troncone LRP, Tufik S. Effects of selective adrenoceptor agonists and antagonists on aggressive behavior elicited by apomorphine, DL-dopa and fusaric acid in REM-sleep-deprived rats. Physiol Behav. 1991;50:173-178.
60. Pellis SM, Castaneda E, McKenna MM, Tran-Nguyen LTL, Whishaw IQ. The role of the striatum in organizing sequences of play fighting in neonatally dopamine-depleted rats Neurosci Lett. 1993;158:13-15
61. Sweidan S, Edinger H, Siegel A. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate affective defense behavior in the cat Brain Res. 1991;549:127-137.
62. Shaikh MB, Lu CL, MacGregor M, Siegel A. Dopaminergic regulation of quiet biting attack behavior in the cat. Brain Res Bull. 1991;27:725-730.
63. Akai T, Yamaguchi M, Mizuta E, Kuno S. Effects of terguride, a partial D2 agonist, on MPTP-lesioned parkinsonian cynomolgus monkeys. Ann Neurol. 1993; 33 507-511.
64. Deutsch AY, Goldstein M, Baldino F, Roth RH Telencephalic projections of the A8 dopamine cell group. In: Kalivas PW, Nemeroff CB, eds. The Mesocorticolimbic Dopamine System New York, NY. NY Academy of Sciences, 1988:27-50.
65. Asberg M, Traskman L, Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor? Arch Gen Psychiatry 1976;33:1193-1197.
66. Greenwald BS, Marin DB, Silverman SM. Depressed 5-hydroxyindole levels associated with hyperactive and aggressive behavior: relationship to drug response. Arch Gen Psychiatry. 1976;33:331-336.
67. Brown G, Ebert M, Goyer P, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am J Psychiatry 1982;139:741-746.
68. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin F. Low cerebrospinal fluid 5-hydoxyindolacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sci. 1983,33 2609-2614
69. Virkkunen M, Nuutila A, Goodwin F, Linnoila M. Cerebrospinal fluid monoamines in male arsonists Arch Gen Psychiatry. 1987;44:241-247.
70. Roy A, DeJong J, Linnoila M. Cerebrospinal fluid monoamine metabolites and suicidal behavior in depressed patients: a 5 year follow-up study. Arch Gen Psychiatry. 1989;46.609-612.
71. Moyer KE. Biological substrates of aggression. Prog Brain Res. 1980,53:361-367.
72. Bear D. Neurological perspectives on aggressive behavior. J Neuropsychiatry Clin Neurosci. 1991,3 S3-S8
73. Elliot FA Violence: the neurologic contribution: an overview. Arch Neurol. 1992; 49 595-603.
74. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK Senile dementia of Lewy body type: a clinically and neuropathologically distinct form of Lewy body dementia in the elderly J Neurol Sci. 1990;95:119-139
75. Forstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy-body variant of Alzheimer's disease, clinical and pathological findings. Br J Psychiatry. 1993.162: 385-392